PDPS Trademark
Trademark Overview
On Friday, May 12, 2023, a trademark application was filed for PDPS with the United States Patent and Trademark Office. The USPTO has given the PDPS trademark a serial number of 97933969. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, December 18, 2024. This trademark is owned by PeptiDream Inc.. The PDPS trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; Manufacture of pharmaceuticals and chemicals to the order and specification of others; Manufacture of synthetic proteins to the order and specification of others; Amino acid synthesis for others, namely, manufacture of amino acids to the order and specification of others
Synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; Chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; Central nervous system drugs, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions affecting the central nervous system; Peripheral nerve drugs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting the peripheral nervous system; Drugs affecting sensory organs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting sensory organs; Antiallergic drugs, namely, pharmaceutical antiallergic preparations and substances; Cardiovascular drugs, namely, cardiovascular pharmaceutical preparations; Drugs affecting respiratory organs, namely, pharmaceutical preparations for treating r...
Chemicals for the manufacture of pharmaceuticals; synthesized peptides for scientific and research use; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use
Testing, examination, namely, inspection and research services in the field of pharmaceuticals, cosmetics, and foods, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical organisms or bacteria, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of chemistry, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical care, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of biotechnology, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit lead peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services ...
General Information
| Serial Number | 97933969 |
| Word Mark | PDPS |
| Filing Date | Friday, May 12, 2023 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, December 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; Manufacture of pharmaceuticals and chemicals to the order and specification of others; Manufacture of synthetic proteins to the order and specification of others; Amino acid synthesis for others, namely, manufacture of amino acids to the order and specification of others |
| Goods and Services | Synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; Chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; Central nervous system drugs, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions affecting the central nervous system; Peripheral nerve drugs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting the peripheral nervous system; Drugs affecting sensory organs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting sensory organs; Antiallergic drugs, namely, pharmaceutical antiallergic preparations and substances; Cardiovascular drugs, namely, cardiovascular pharmaceutical preparations; Drugs affecting respiratory organs, namely, pharmaceutical preparations for treating respiratory diseases; Drugs affecting digestive organs, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions affecting digestive organs; Drugs for outer skin, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions for skin care; Pharmaceutical preparations for the treatment of various diseases and medical conditions of Metabolic disorders; Cellular function activating drugs for the treatment of various diseases and medical conditions for medical purposes; Pharmaceutical preparations for the treatment of various diseases and medical conditions for suppressing tumors; diagnostic preparations for medical purposes; Pharmaceutical preparations using synthesized peptides used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes; Synthesized proteins and chemical preparations used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes |
| Goods and Services | Chemicals for the manufacture of pharmaceuticals; synthesized peptides for scientific and research use; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use |
| Goods and Services | Testing, examination, namely, inspection and research services in the field of pharmaceuticals, cosmetics, and foods, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical organisms or bacteria, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of chemistry, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical care, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of biotechnology, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit lead peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit-lead compounds, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of proteins, and the provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the fields of pharmaceuticals, cosmetics, foods, medical organisms or
bacteria, chemistry, medical care, biotechnology, identification of hit lead peptides, analysis and synthesis of peptides, using automated screening machines and the provision of information or advice thereto; Scientific research in the nature of conduction of clinical trials for others; Quality control of peptides used in drug development; Advice on quality control of peptides used in drug development |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | PeptiDream Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Kawasaki-Shi, Kanagawa 210-0821
JP |
Trademark Events
| Event Date | Event Description |
| Tuesday, May 16, 2023 | NEW APPLICATION ENTERED |
| Monday, June 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 6, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 7, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 18, 2024 | ASSIGNED TO LIE |
| Tuesday, September 24, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, September 24, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 24, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 13, 2024 | ASSIGNED TO LIE |
| Friday, December 13, 2024 | DATA MODIFICATION COMPLETED |
| Tuesday, December 17, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 17, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 17, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 17, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
